Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Satellos Bioscience Inc.
Market Cap
$10.41M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.51M
Net Profit Margin
N/A
TTM Avg
-2424.09%
3Y Avg
-1624.47%
5Y Avg
-1082.98%
Market Cap
$10.58M
Net Profit Margin
-90116.36%
TTM Avg
-139631.82%
3Y Avg
-71156.88%
5Y Avg
-48680.54%
Market Cap
$10.22M
Net Profit Margin
-141.28%
TTM Avg
-101.58%
3Y Avg
-179.50%
5Y Avg
-204.48%
Market Cap
$10.13M
Net Profit Margin
0.00%
TTM Avg
-496.48%
3Y Avg
-440.58%
5Y Avg
-356.69%
Market Cap
$10.10M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.79M
Net Profit Margin
-2406.00%
TTM Avg
-2017.47%
3Y Avg
-5077.56%
5Y Avg
-6322.50%
Market Cap
$10.82M
Net Profit Margin
-666037.76%
TTM Avg
-148948.78%
3Y Avg
-148948.78%
5Y Avg
-148948.78%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Satellos Bioscience Inc. (MSLE) | $10.41M | 0.00% | 0.00% | 0.00% | 0.00% |
| Polyrizon Ltd. (PLRZ)vs › | $10.42M | N/A | 0.00% | 0.00% | 0.00% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | -2424.09% | -1624.47% | -1082.98% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.58M | -90116.36% | -139631.82% | -71156.88% | -48680.54% |
| Lifeward Ltd. (LFWD)vs › | $10.22M | -141.28% | -101.58% | -179.50% | -204.48% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | 0.00% | -496.48% | -440.58% | -356.69% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pluri Inc. (PLUR)vs › | $10.79M | -2406.00% | -2017.47% | -5077.56% | -6322.50% |
| Caring Brands, Inc. (CABR)vs › | $10.82M | -666037.76% | -148948.78% | -148948.78% | -148948.78% |
| Valion Bio, Inc. (VBIO)vs › | $9.90M | 0.00% | 0.00% | -312.43% | -391.43% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
